These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 18234531)
1. Idebenone treatment in paediatric and adult patients with Friedreich ataxia: long-term follow-up. Pineda M; Arpa J; Montero R; Aracil A; Domínguez F; Galván M; Mas A; Martorell L; Sierra C; Brandi N; García-Arumí E; Rissech M; Velasco D; Costa JA; Artuch R Eur J Paediatr Neurol; 2008 Nov; 12(6):470-5. PubMed ID: 18234531 [TBL] [Abstract][Full Text] [Related]
2. Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up. Ribaï P; Pousset F; Tanguy ML; Rivaud-Pechoux S; Le Ber I; Gasparini F; Charles P; Béraud AS; Schmitt M; Koenig M; Mallet A; Brice A; Dürr A Arch Neurol; 2007 Apr; 64(4):558-64. PubMed ID: 17420319 [TBL] [Abstract][Full Text] [Related]
3. Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia. Velasco-Sánchez D; Aracil A; Montero R; Mas A; Jiménez L; O'Callaghan M; Tondo M; Capdevila A; Blanch J; Artuch R; Pineda M Cerebellum; 2011 Mar; 10(1):1-8. PubMed ID: 20865357 [TBL] [Abstract][Full Text] [Related]
4. A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia. Lynch DR; Perlman SL; Meier T Arch Neurol; 2010 Aug; 67(8):941-7. PubMed ID: 20697044 [TBL] [Abstract][Full Text] [Related]
5. Friedreich's ataxia: idebenone treatment in early stage patients. Artuch R; Aracil A; Mas A; Colomé C; Rissech M; Monrós E; Pineda M Neuropediatrics; 2002 Aug; 33(4):190-3. PubMed ID: 12368988 [TBL] [Abstract][Full Text] [Related]
6. Antioxidants and other pharmacological treatments for Friedreich ataxia. Kearney M; Orrell RW; Fahey M; Pandolfo M Cochrane Database Syst Rev; 2012 Apr; (4):CD007791. PubMed ID: 22513953 [TBL] [Abstract][Full Text] [Related]
7. Antioxidants and other pharmacological treatments for Friedreich ataxia. Kearney M; Orrell RW; Fahey M; Pandolfo M Cochrane Database Syst Rev; 2009 Oct; (4):CD007791. PubMed ID: 19821439 [TBL] [Abstract][Full Text] [Related]
8. Plasma idebenone monitoring in Friedreich's ataxia patients during a long-term follow-up. Paredes-Fuentes AJ; Cesar S; Montero R; Latre C; Genovès J; Martorell L; Cuadras D; Colom H; Pineda M; Del Mar O'Callaghan M; Sarquella-Brugada G; Darling A; Artuch R Biomed Pharmacother; 2021 Nov; 143():112143. PubMed ID: 34507114 [TBL] [Abstract][Full Text] [Related]
9. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial. Di Prospero NA; Baker A; Jeffries N; Fischbeck KH Lancet Neurol; 2007 Oct; 6(10):878-86. PubMed ID: 17826341 [TBL] [Abstract][Full Text] [Related]
10. Clinical experience with high-dose idebenone in Friedreich ataxia. Schulz JB; Di Prospero NA; Fischbeck K J Neurol; 2009 Mar; 256 Suppl 1(0 1):42-5. PubMed ID: 19283350 [TBL] [Abstract][Full Text] [Related]
11. Idebenone: an emerging therapy for Friedreich ataxia. Meier T; Buyse G J Neurol; 2009 Mar; 256 Suppl 1():25-30. PubMed ID: 19283347 [TBL] [Abstract][Full Text] [Related]
12. Idebenone in Friedreich's ataxia. Tonon C; Lodi R Expert Opin Pharmacother; 2008 Sep; 9(13):2327-37. PubMed ID: 18710357 [TBL] [Abstract][Full Text] [Related]
13. Clinical Experience With Deferiprone Treatment for Friedreich Ataxia. Elincx-Benizri S; Glik A; Merkel D; Arad M; Freimark D; Kozlova E; Cabantchik I; Hassin-Baer S J Child Neurol; 2016 Jul; 31(8):1036-40. PubMed ID: 27029487 [TBL] [Abstract][Full Text] [Related]
14. Neurophysiological evaluation in children with Friedreich's ataxia. Sival DA; du Marchie Sarvaas GJ; Brouwer OF; Uges DR; Verschuuren-Bemelmans CC; Maurits NM; Brunt ER; van der Hoeven JH Early Hum Dev; 2009 Oct; 85(10):647-51. PubMed ID: 19775837 [TBL] [Abstract][Full Text] [Related]
15. Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA). Lagedrost SJ; Sutton MS; Cohen MS; Satou GM; Kaufman BD; Perlman SL; Rummey C; Meier T; Lynch DR Am Heart J; 2011 Mar; 161(3):639-645.e1. PubMed ID: 21392622 [TBL] [Abstract][Full Text] [Related]
16. Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study. Meier T; Perlman SL; Rummey C; Coppard NJ; Lynch DR J Neurol; 2012 Feb; 259(2):284-91. PubMed ID: 21779958 [TBL] [Abstract][Full Text] [Related]
17. [Successful idebenone therapy of hypertrophic cardiomyopathy in Friedreich ataxia]. Kádár K Orv Hetil; 2003 Jun; 144(25):1241-4. PubMed ID: 12901180 [TBL] [Abstract][Full Text] [Related]
18. Intermediate-dose idebenone and quality of life in Friedreich ataxia. Brandsema JF; Stephens D; Hartley J; Yoon G Pediatr Neurol; 2010 May; 42(5):338-42. PubMed ID: 20399388 [TBL] [Abstract][Full Text] [Related]
19. Low-dose idebenone treatment in Friedreich's ataxia with and without cardiac hypertrophy. Rinaldi C; Tucci T; Maione S; Giunta A; De Michele G; Filla A J Neurol; 2009 Sep; 256(9):1434-7. PubMed ID: 19363628 [TBL] [Abstract][Full Text] [Related]
20. Idebenone in patients with Friedreich ataxia. Schöls L; Vorgerd M; Schillings M; Skipka G; Zange J Neurosci Lett; 2001 Jun; 306(3):169-72. PubMed ID: 11406322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]